{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:29:05Z","timestamp":1793957345813,"version":"4.8.0"},"reference-count":235,"publisher":"Oxford University Press (OUP)","issue":"30","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiac sarcoidosis (CS) is a form of inflammatory cardiomyopathy associated with significant clinical complications such as high-degree atrioventricular block, ventricular tachycardia, and heart failure as well as sudden cardiac death. It is therefore important to provide an expert consensus statement summarizing the role of different available diagnostic tools and emphasizing the importance of a multidisciplinary approach. By integrating clinical information and the results of diagnostic tests, an accurate, validated, and timely diagnosis can be made, while alternative diagnoses can be reasonably excluded. This clinical expert consensus statement reviews the evidence on the management of different CS manifestations and provides advice to practicing clinicians in the field on the role of immunosuppression and the treatment of cardiac complications based on limited published data and the experience of international CS experts. The monitoring and risk stratification of patients with CS is also covered, while controversies and future research needs are explored.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehae356","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T10:18:26Z","timestamp":1716373106000},"page":"2697-2726","source":"Crossref","is-referenced-by-count":104,"title":["Management of cardiac sarcoidosis"],"prefix":"10.1093","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9418-2655","authenticated-orcid":false,"given":"Rakesh","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Cardiology, Royal Brompton Hospital, part of Guy's and St Thomas's NHS Foundation Trust , London SW3 6NP,","place":["UK"]},{"name":"National Heart and Lung Institute , Imperial College London,","place":["UK"]},{"name":"King's College London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Kouranos","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute , Imperial College London,","place":["UK"]},{"name":"Interstitial Lung Disease Unit, Royal Brompton Hospital, part of Guys and St. Thomas\u2019s Hospital , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie T","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic in Florida , 4500 San Pablo, Jacksonville,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-8568","authenticated-orcid":false,"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"Cardiology Unit, ASST Spedali Civili, University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsen","family":"Ristic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Belgrade , Pasterova 2, Floor 9, 11000 Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Heidecker","sequence":"additional","affiliation":[{"name":"Department for Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9, Campus Benjamin Franklin; Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin Institute of Health (BIH) at Charit\u00e9 , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Baksi","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute , Imperial College London,","place":["UK"]},{"name":"Cardiac MRI Unit, Royal Brompton Hospital, part of Guy's and St Thomas's NHS Foundation Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Wicks","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Oxford University Hospitals NHS Trust , Oxford,","place":["UK"]},{"name":"University College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L","family":"Merino","sequence":"additional","affiliation":[{"name":"La Paz University Hospital-IdiPaz, Universidad Autonoma , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0203-2498","authenticated-orcid":false,"given":"Karin","family":"Klingel","sequence":"additional","affiliation":[{"name":"University Hospital Tubingen , T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-0245","authenticated-orcid":false,"given":"Massimo","family":"Imazio","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Udine , Udine ,","place":["Italy"]},{"name":"Department of Cardiology, University Hospital Santa Maria della Misericordia , Udine ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"de Chillou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, CHRU-Nancy, Universit\u00e9 de Lorraine , Nancy ,","place":["France"]},{"name":"Department of Cardiology, IADI, INSERM U1254, Universit\u00e9 de Lorraine , Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Tsch\u00f6pe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Deutsches Herzzentrum der Charit\u00e9 (DHZC), Angiology and Intensive Medicine (Campus Virchow) and German Centre for Cardiovascular Research (DZHK)- partner site Berlin, Charit\u00e9 Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]},{"name":"Berlin Institute of Health (BIH) at Charit\u00e9 - Center for Regenerative Therapies, Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Kuchynka","sequence":"additional","affiliation":[{"name":"2nd Department of Medicine, Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital , Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-5160","authenticated-orcid":false,"given":"Steffen E","family":"Petersen","sequence":"additional","affiliation":[{"name":"NIHR Barts Biomedical Research Centre, William Harvey Research Institute, Queen Mary University London, Charterhouse Square , London, EC1M 6BQ ,","place":["UK"]},{"name":"Barts Heart Centre, St Bartholomew\u2019s Hospital, Barts Health NHS Trust , West Smithfield, EC1A 7BE, London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"McDonagh","sequence":"additional","affiliation":[{"name":"Department of Cardiology King\u2019s College Hospital , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"L\u00fcscher","sequence":"additional","affiliation":[{"name":"Royal Brompton Hospital, part of Guys and St Thomas\u2019s NHS Foundation Trust, Professor of Cardiology at Imperial College and Kings College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"2025112103172981800_ehae356-B1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/pgmj.34.391.245","article-title":"The historical aspects of sarcoidosis","volume":"34","author":"Danbolt","year":"1958","journal-title":"Postgrad Med J"},{"key":"2025112103172981800_ehae356-B2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2025112103172981800_ehae356-B3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/heartjnl-2019-316442","article-title":"Cardiac sarcoidosis: state-of-the-art review","volume":"107","author":"Kouranos","year":"2021","journal-title":"Heart"},{"key":"2025112103172981800_ehae356-B4","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","article-title":"Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis","volume":"44","author":"Lehtonen","year":"2023","journal-title":"Eur Heart J"},{"key":"2025112103172981800_ehae356-B5","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis- digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"2025112103172981800_ehae356-B6","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstr\u00f6m","year":"2019","journal-title":"Eur Heart J"},{"key":"2025112103172981800_ehae356-B7","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1183\/13993003.00457-2016","article-title":"Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis","volume":"48","author":"Jamilloux","year":"2016","journal-title":"Eur Respir J"},{"key":"2025112103172981800_ehae356-B8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"2025112103172981800_ehae356-B9","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ejhf.3057","article-title":"Predictors of outcome in a contemporary cardiac sarcoidosis population: role of brain natriuretic peptide, left ventricular function and myocardial inflammation","volume":"25","author":"Kouranos","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2025112103172981800_ehae356-B10","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2025112103172981800_ehae356-B11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","journal-title":"Am Heart J"},{"key":"2025112103172981800_ehae356-B12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025112103172981800_ehae356-B13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B14","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B15","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"2025112103172981800_ehae356-B16","doi-asserted-by":"crossref","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B17","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"2025112103172981800_ehae356-B18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1378\/chest.10-0413","article-title":"Sarcoidosis in black women in the United States: data from the Black Women's Health Study","volume":"139","author":"Cozier","year":"2011","journal-title":"Chest"},{"key":"2025112103172981800_ehae356-B19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/oxfordjournals.aje.a114313","article-title":"The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival","volume":"123","author":"Henke","year":"1986","journal-title":"Am J Epidemiol"},{"key":"2025112103172981800_ehae356-B20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"2025112103172981800_ehae356-B21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","article-title":"Epidemiology of sarcoidosis 1946\u20132013: a population-based study","volume":"91","author":"Ungprasert","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2025112103172981800_ehae356-B22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"2025112103172981800_ehae356-B23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14797\/mdcvj.1057","article-title":"Epidemiology, pathogenesis, and diagnosis of cardiac sarcoidosis","volume":"18","author":"Mathai","year":"2022","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"2025112103172981800_ehae356-B24","doi-asserted-by":"crossref","first-page":"1900444","DOI":"10.1183\/13993003.00444-2019","article-title":"Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study","volume":"54","author":"Fidler","year":"2019","journal-title":"Eur Respir J"},{"key":"2025112103172981800_ehae356-B25","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America. Analysis based on health care use","volume":"13","author":"Baughman","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2025112103172981800_ehae356-B26","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/thx.2006.062836","article-title":"Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK","volume":"61","author":"Gribbin","year":"2006","journal-title":"Thorax"},{"key":"2025112103172981800_ehae356-B27","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2025112103172981800_ehae356-B28","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1513\/AnnalsATS.201806-401RL","article-title":"Sarcoidosis-associated hospitalizations in the United States, 2002 to 2012","volume":"15","author":"Wills","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2025112103172981800_ehae356-B29","doi-asserted-by":"crossref","first-page":"e006145","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025112103172981800_ehae356-B30","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.121.058120","article-title":"Incidence of sudden cardiac death and life-threatening arrhythmias in clinically manifest cardiac sarcoidosis with and without current indications for an implantable cardioverter defibrillator","volume":"146","author":"Nordenswan","year":"2022","journal-title":"Circulation"},{"key":"2025112103172981800_ehae356-B31","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2025112103172981800_ehae356-B32","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","article-title":"Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden","volume":"48","author":"Arkema","year":"2016","journal-title":"Eur Respir J"},{"key":"2025112103172981800_ehae356-B33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/heartjnl-2022-322243","article-title":"Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis","volume":"109","author":"Iso","year":"2023","journal-title":"Heart"},{"key":"2025112103172981800_ehae356-B34","doi-asserted-by":"crossref","first-page":"106564","DOI":"10.1016\/j.rmed.2021.106564","article-title":"The impact of demographic disparities in the presentation of sarcoidosis: a multicenter prospective study","volume":"187","author":"Zhou","year":"2021","journal-title":"Respir Med"},{"key":"2025112103172981800_ehae356-B35","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cardfail.2023.03.022","article-title":"Sex and race differences in cardiac sarcoidosis presentation, treatment and outcomes","volume":"29","author":"Duvall","year":"2023","journal-title":"J Card Fail"},{"key":"2025112103172981800_ehae356-B36","doi-asserted-by":"crossref","first-page":"e009966","DOI":"10.1161\/CIRCEP.121.009966","article-title":"Sex differences in patients with suspected cardiac sarcoidosis assessed by cardiovascular magnetic resonance imaging","volume":"14","author":"Kalra","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025112103172981800_ehae356-B37","doi-asserted-by":"crossref","first-page":"e4518","DOI":"10.1097\/MD.0000000000004518","article-title":"Prevalence of cardiac sarcoidosis in white population: a case-control study: proposal for a novel risk index based on commonly available tests","volume":"95","author":"Martusewicz-Boros","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025112103172981800_ehae356-B38","first-page":"128","article-title":"Mortality among African American women with sarcoidosis: data from the Black Women\u2019s Health Study","volume":"30","author":"Tukey","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025112103172981800_ehae356-B39","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2025112103172981800_ehae356-B40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/thoraxjnl-2019-214348","article-title":"BTS clinical statement on pulmonary sarcoidosis","volume":"76","author":"Thillai","year":"2021","journal-title":"Thorax"},{"key":"2025112103172981800_ehae356-B41","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025112103172981800_ehae356-B42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrcardio.2015.22","article-title":"Pathophysiology and clinical management of cardiac sarcoidosis","volume":"12","author":"Hamzeh","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2025112103172981800_ehae356-B43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1465-9921-15-15","article-title":"Cardiac involvement in Caucasian patients with pulmonary sarcoidosis","volume":"15","author":"Darlington","year":"2014","journal-title":"Respir Res"},{"key":"2025112103172981800_ehae356-B44","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1073\/pnas.76.12.6646","article-title":"Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas","volume":"76","author":"Silverstein","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112103172981800_ehae356-B45","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"2025112103172981800_ehae356-B46","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1373\/49.9.1510","article-title":"Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis","volume":"49","author":"Rothkrantz-Kos","year":"2003","journal-title":"Clin Chem"},{"key":"2025112103172981800_ehae356-B47","doi-asserted-by":"crossref","first-page":"e0223897","DOI":"10.1371\/journal.pone.0223897","article-title":"Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis","volume":"14","author":"Eurelings","year":"2019","journal-title":"PLoS One"},{"key":"2025112103172981800_ehae356-B48","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1084\/jem.183.4.1587","article-title":"Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding","volume":"183","author":"Junghans","year":"1996","journal-title":"J Exp Med"},{"key":"2025112103172981800_ehae356-B49","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025112103172981800_ehae356-B50","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2025112103172981800_ehae356-B51","first-page":"11","article-title":"Diagnostic approach for cardiac involvement in sarcoidosis","volume":"36","author":"Darlington","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025112103172981800_ehae356-B52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1536\/ihj.53.287","article-title":"Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis","volume":"53","author":"Baba","year":"2012","journal-title":"Int Heart J"},{"key":"2025112103172981800_ehae356-B53","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1536\/ihj.17-695","article-title":"A multiple biomarker approach in patients with cardiac sarcoidosis","volume":"59","author":"Kiko","year":"2018","journal-title":"Int Heart J"},{"key":"2025112103172981800_ehae356-B54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijcard.2004.05.028","article-title":"Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter","volume":"102","author":"Yasutake","year":"2005","journal-title":"Int J Cardiol"},{"key":"2025112103172981800_ehae356-B55","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2015.06.021","article-title":"Usefulness of cardiac troponins as markers of early treatment response in cardiac sarcoidosis","volume":"116","author":"Kandolin","year":"2015","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B56","doi-asserted-by":"crossref","first-page":"e008968","DOI":"10.1161\/JAHA.118.008968","article-title":"Elevated Sera sST2 is associated with heart failure in men \u226450 years old with myocarditis","volume":"8","author":"Coronado","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025112103172981800_ehae356-B57","doi-asserted-by":"crossref","first-page":"e024417","DOI":"10.1161\/JAHA.121.024417","article-title":"Soluble ST2 is a sensitive and specific biomarker for fulminant myocarditis","volume":"11","author":"Wang","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025112103172981800_ehae356-B58","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1540-8167.2011.02099.x","article-title":"Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement","volume":"22","author":"Schuller","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025112103172981800_ehae356-B59","doi-asserted-by":"crossref","first-page":"e0238391","DOI":"10.1371\/journal.pone.0238391","article-title":"Cardiac sarcoidosis: a long term follow up study","volume":"15","author":"Cacoub","year":"2020","journal-title":"PLoS One"},{"key":"2025112103172981800_ehae356-B60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","article-title":"Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults","volume":"4","author":"Kandolin","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025112103172981800_ehae356-B61","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00380-022-02229-2","article-title":"Fragmented QRS on 12-lead electrocardiogram predicts long-term prognosis in patients with cardiac sarcoidosis","volume":"38","author":"Hagiwara","year":"2023","journal-title":"Heart Vessels"},{"key":"2025112103172981800_ehae356-B62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1542-474X.2009.00320.x","article-title":"Fragmented QRS complexes on 12-lead ECG: a marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging","volume":"14","author":"Homsi","year":"2009","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2025112103172981800_ehae356-B63","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1378\/chest.106.4.1021","article-title":"Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis","volume":"106","author":"Suzuki","year":"1994","journal-title":"Chest"},{"key":"2025112103172981800_ehae356-B64","doi-asserted-by":"crossref","first-page":"e024924","DOI":"10.1161\/JAHA.121.024924","article-title":"Arrhythmia monitoring and outcomes in patients with cardiac sarcoidosis: insights from the Cardiac Sarcoidosis Consortium","volume":"11","author":"Bressi","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025112103172981800_ehae356-B65","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00259-020-05066-5","article-title":"Procedural recommendations of cardiac PET\/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM","volume":"48","author":"Slart","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025112103172981800_ehae356-B66","doi-asserted-by":"crossref","first-page":"e000867","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B67","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1378\/chest.109.1.62","article-title":"Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis","volume":"109","author":"Fahy","year":"1996","journal-title":"Chest"},{"key":"2025112103172981800_ehae356-B68","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1253\/circj.CJ-14-1217","article-title":"Association between basal thinning of interventricular septum and adverse long-term clinical outcomes in patients with cardiac sarcoidosis","volume":"79","author":"Nagano","year":"2015","journal-title":"Circ J"},{"key":"2025112103172981800_ehae356-B69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.resinv.2022.02.001","article-title":"Basal interventricular septum thinning and long-term left ventricular function in patients with sarcoidosis","volume":"60","author":"Tanizawa","year":"2022","journal-title":"Respir Investig"},{"key":"2025112103172981800_ehae356-B70","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ccm.2008.03.005","article-title":"Cardiac sarcoidosis","volume":"29","author":"Ayyala","year":"2008","journal-title":"Clin Chest Med"},{"key":"2025112103172981800_ehae356-B71","doi-asserted-by":"crossref","first-page":"809594","DOI":"10.3389\/fcvm.2021.809594","article-title":"Prevalence of sarcoidosis-associated pulmonary hypertension: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025112103172981800_ehae356-B72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12872-019-01323-0","article-title":"Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis","volume":"20","author":"Di Stefano","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"2025112103172981800_ehae356-B73","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/echo.13281","article-title":"Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction","volume":"33","author":"Murtagh","year":"2016","journal-title":"Echocardiography"},{"key":"2025112103172981800_ehae356-B74","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/echo.13846","article-title":"Global longitudinal strain and long-term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease","volume":"35","author":"Felekos","year":"2018","journal-title":"Echocardiography"},{"key":"2025112103172981800_ehae356-B75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12968-020-00607-1","article-title":"Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update","volume":"22","author":"Kramer","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025112103172981800_ehae356-B76","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamacardio.2022.2981","article-title":"Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis","volume":"7","author":"Athwal","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2025112103172981800_ehae356-B77","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/ehjci\/jeac265","article-title":"Cardiac magnetic resonance in giant cell myocarditis: a matched comparison with cardiac sarcoidosis","volume":"24","author":"P\u00f6yh\u00f6nen","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B78","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s10554-020-01923-4","article-title":"Reproducibility of cardiac magnetic resonance imaging in patients referred for the assessment of cardiac sarcoidosis; implications for clinical practice","volume":"36","author":"Juneau","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B79","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"2025112103172981800_ehae356-B80","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur Heart J"},{"key":"2025112103172981800_ehae356-B81","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025112103172981800_ehae356-B82","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B83","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"2025112103172981800_ehae356-B84","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"2025112103172981800_ehae356-B85","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B86","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2967\/jnumed.112.105155","article-title":"SNMMI\/ASNC\/SCCT guideline for cardiac SPECT\/CT and PET\/CT 1.0","volume":"54","author":"Dorbala","year":"2013","journal-title":"J Nucl Med"},{"key":"2025112103172981800_ehae356-B87","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","article-title":"A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology","volume":"18","author":"Writing Group","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B88","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (18)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B89","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10554-013-0339-y","article-title":"The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy","volume":"30","author":"Paz","year":"2014","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B90","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.hrthm.2015.08.014","article-title":"Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"2025112103172981800_ehae356-B91","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B92","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12350-009-9110-0","article-title":"Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis","volume":"16","author":"Langah","year":"2009","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B93","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med"},{"key":"2025112103172981800_ehae356-B94","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B95","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12350-012-9653-3","article-title":"Clinical value of a high-fat and low-carbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis","volume":"20","author":"Soussan","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B96","doi-asserted-by":"crossref","first-page":"W151","DOI":"10.2214\/AJR.07.2409","article-title":"Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet","volume":"190","author":"Williams","year":"2008","journal-title":"Am J Roentgenol"},{"key":"2025112103172981800_ehae356-B97","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","article-title":"The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis","volume":"23","author":"Manabe","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B98","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0284185115600916","article-title":"Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart","volume":"57","author":"Masuda","year":"2016","journal-title":"Acta Radiol"},{"key":"2025112103172981800_ehae356-B99","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s12350-023-03346-9","article-title":"Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis","volume":"30","author":"Kherajani","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025112103172981800_ehae356-B101","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1095-0397(01)00062-0","article-title":"Reduction of myocardial 2-deoxy-2-[18F]fluoro-D-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction","volume":"4","author":"Lum","year":"2002","journal-title":"Mol Imaging Biol"},{"key":"2025112103172981800_ehae356-B102","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00259-011-1832-y","article-title":"(18)F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"38","author":"Ohira","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025112103172981800_ehae356-B103","first-page":"1","article-title":"Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin)","volume":"724","author":"Persson","year":"1988","journal-title":"Acta Med Scand Suppl"},{"key":"2025112103172981800_ehae356-B104","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B105","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"2025112103172981800_ehae356-B106","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B107","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2025112103172981800_ehae356-B108","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCIMAGING.112.000289","article-title":"Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by (18)F-fluorodoexyglucose positron emission tomography?","volume":"6","author":"Mc Ardle","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B109","first-page":"1571","article-title":"Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis","volume":"47","author":"Nishiyama","year":"2006","journal-title":"J Nucl Med"},{"key":"2025112103172981800_ehae356-B110","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2967\/jnumed.116.187203","article-title":"Inter- and intraobserver agreement of (18)F-FDG PET\/CT image interpretation in patients referred for assessment of cardiac sarcoidosis","volume":"58","author":"Ohira","year":"2017","journal-title":"J Nucl Med"},{"key":"2025112103172981800_ehae356-B111","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ahj.2004.10.006","article-title":"A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy","volume":"150","author":"Ardehali","year":"2005","journal-title":"Am Heart J"},{"key":"2025112103172981800_ehae356-B112","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2025112103172981800_ehae356-B113","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J Intern Med"},{"key":"2025112103172981800_ehae356-B114","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.amjcard.2015.01.562","article-title":"Comparison of outcomes in patients with probable versus definite cardiac sarcoidosis","volume":"115","author":"Takaya","year":"2015","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B115","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/ehf2.12725","article-title":"Idiopathic giant cell myocarditis or cardiac sarcoidosis? A retrospective audit of a nationwide case series","volume":"7","author":"Ekstr\u00f6m","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2025112103172981800_ehae356-B116","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCRESAHA.121.320449","article-title":"Transcriptional and immune landscape of cardiac sarcoidosis","volume":"131","author":"Liu","year":"2022","journal-title":"Circ Res"},{"key":"2025112103172981800_ehae356-B117","first-page":"736","article-title":"Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS board of directors and by the ERS Executive Committee, February 1999","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2025112103172981800_ehae356-B118","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2213-2600(23)00267-9","article-title":"High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study","volume":"12","author":"Desai","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2025112103172981800_ehae356-B119","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025112103172981800_ehae356-B120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ahj.2020.02.008","article-title":"Performance of diagnostic criteria in patients clinically judged to have cardiac sarcoidosis: is it time to regroup?","volume":"223","author":"Ribeiro Neto","year":"2020","journal-title":"Am Heart J"},{"key":"2025112103172981800_ehae356-B121","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/heartjnl-2022-321379","article-title":"Cardiac sarcoidosis","volume":"109","author":"Sohn","year":"2023","journal-title":"Heart"},{"key":"2025112103172981800_ehae356-B122","doi-asserted-by":"crossref","first-page":"131143","DOI":"10.1016\/j.ijcard.2023.131143","article-title":"Phenotyping of giant cell myocarditis versus cardiac sarcoidosis using cardiovascular magnetic resonance","volume":"387","author":"Bobbio","year":"2023","journal-title":"Int J Cardiol"},{"key":"2025112103172981800_ehae356-B123","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12872-022-02639-0","article-title":"Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a Swedish single center experience","volume":"22","author":"Bobbio","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"2025112103172981800_ehae356-B124","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"key":"2025112103172981800_ehae356-B125","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s12350-021-02886-2","article-title":"(18)F-FDG\/(13)N-ammonia cardiac PET findings in ATTR cardiac amyloidosis","volume":"30","author":"Young","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B126","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12350-022-02960-3","article-title":"Quantitative (99m)Tc-DPD-SPECT\/CT assessment of cardiac amyloidosis","volume":"30","author":"Kessler","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B127","doi-asserted-by":"crossref","first-page":"614","DOI":"10.12968\/hmed.2016.77.11.614","article-title":"Accurate diagnosis of cardiac sarcoidosis needs a multidisciplinary approach","volume":"77","author":"Kouranos","year":"2016","journal-title":"Br J Hosp Med (Lond)"},{"key":"2025112103172981800_ehae356-B128","first-page":"277","article-title":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001","volume":"165","author":"American Thoracic Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2025112103172981800_ehae356-B129","doi-asserted-by":"crossref","first-page":"545413","DOI":"10.3389\/fimmu.2020.545413","article-title":"Treatment of sarcoidosis: a multidisciplinary approach","volume":"11","author":"Gerke","year":"2020","journal-title":"Front Immunol"},{"key":"2025112103172981800_ehae356-B130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s41030-021-00161-w","article-title":"A comprehensive review of sarcoidosis diagnosis and monitoring for the pulmonologist","volume":"7","author":"Melani","year":"2021","journal-title":"Pulm Ther"},{"key":"2025112103172981800_ehae356-B131","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"key":"2025112103172981800_ehae356-B132","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cardfail.2021.06.016","article-title":"Sarcoidosis-Related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review","volume":"28","author":"Gilotra","year":"2022","journal-title":"J Card Fail"},{"key":"2025112103172981800_ehae356-B133","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B134","doi-asserted-by":"crossref","first-page":"e210318","DOI":"10.1148\/ryct.210318","article-title":"Layer-specific strain analysis with cardiac MRI feature tracking in acute myocarditis","volume":"4","author":"Isaak","year":"2022","journal-title":"Radiol Cardiothorac Imaging"},{"key":"2025112103172981800_ehae356-B135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijcard.2016.11.041","article-title":"Increased risk of ventricular tachycardia in patients with sarcoidosis during the very long term follow-up","volume":"228","author":"Te","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025112103172981800_ehae356-B136","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1253\/circj.CJ-17-0701","article-title":"Trends in hospitalizations for cardiac sarcoidosis in the United States, 2005\u20132011","volume":"81","author":"Guo","year":"2017","journal-title":"Circ J"},{"key":"2025112103172981800_ehae356-B137","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5603\/CJ.a2018.0104","article-title":"Cardiac sarcoidosis and ventricular arrhythmias. A rare association of a rare disease. A retrospective cohort study from the national inpatient sample and current evidence for management","volume":"27","author":"Salama","year":"2020","journal-title":"Cardiol J"},{"key":"2025112103172981800_ehae356-B138","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/europace\/eun110","article-title":"Ventricular tachyarrhythmia as a primary presentation of sarcoidosis","volume":"10","author":"Uusimaa","year":"2008","journal-title":"Europace"},{"key":"2025112103172981800_ehae356-B139","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"2025112103172981800_ehae356-B140","doi-asserted-by":"crossref","first-page":"e003353","DOI":"10.1161\/CIRCEP.115.003353","article-title":"Time course and factors correlating with ventricular tachyarrhythmias after introduction of steroid therapy in cardiac sarcoidosis","volume":"9","author":"Segawa","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025112103172981800_ehae356-B141","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/jce.14689","article-title":"Treatment with corticosteroids is associated with an increase in ventricular arrhythmia burden in patients with clinically manifest cardiac sarcoidosis: insights from implantable cardioverter-defibrillator diagnostics","volume":"31","author":"Medor","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025112103172981800_ehae356-B142","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00428-010-1003-8","article-title":"Cardiac sarcoidosis and sudden death. The heart may look normal or mimic other cardiomyopathies","volume":"458","author":"Bagwan","year":"2011","journal-title":"Virchows Arch"},{"key":"2025112103172981800_ehae356-B143","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","article-title":"Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis","volume":"4","author":"Banba","year":"2007","journal-title":"Heart Rhythm"},{"key":"2025112103172981800_ehae356-B144","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCEP.113.000734","article-title":"Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis","volume":"7","author":"Naruse","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025112103172981800_ehae356-B145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","article-title":"Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"16","author":"Yodogawa","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2025112103172981800_ehae356-B146","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/CIRCULATIONAHA.110.990747","article-title":"Coronary artery vasculitis as a presentation of cardiac sarcoidosis","volume":"125","author":"Ward","year":"2012","journal-title":"Circulation"},{"key":"2025112103172981800_ehae356-B147","doi-asserted-by":"crossref","first-page":"e021183","DOI":"10.1161\/JAHA.121.021183","article-title":"Corticosteroid and immunosuppressant therapy for cardiac sarcoidosis: a systematic review","volume":"10","author":"Fazelpour","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2025112103172981800_ehae356-B148","doi-asserted-by":"crossref","first-page":"2100449","DOI":"10.1183\/13993003.00449-2021","article-title":"Cardiac sarcoidosis: systematic review of the literature on corticosteroid and immunosuppressive therapies","volume":"59","author":"Stievenart","year":"2022","journal-title":"Eur Respir J"},{"key":"2025112103172981800_ehae356-B149","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.19102\/icrm.2022.13113","article-title":"Dual medical therapy for treatment of arrhythmias in cardiac sarcoidosis","volume":"13","author":"Sibilia","year":"2022","journal-title":"J Innov Card Rhythm Manag"},{"key":"2025112103172981800_ehae356-B150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamacardio.2017.1413","article-title":"Association of implantable cardioverter defibrillators with survival in patients with and without improved ejection fraction: secondary analysis of the sudden cardiac death in heart failure trial","volume":"2","author":"Adabag","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2025112103172981800_ehae356-B151","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"2025112103172981800_ehae356-B152","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"2025112103172981800_ehae356-B153","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart"},{"key":"2025112103172981800_ehae356-B154","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jcmg.2019.12.011","article-title":"Right ventricular abnormalities on cardiovascular magnetic resonance imaging in patients with sarcoidosis","volume":"13","author":"Velangi","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B155","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s00392-019-01591-y","article-title":"Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging","volume":"109","author":"Kagioka","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"2025112103172981800_ehae356-B156","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMoa1210356","article-title":"Biventricular pacing for atrioventricular block and systolic dysfunction","volume":"368","author":"Curtis","year":"2013","journal-title":"N Engl J Med"},{"key":"2025112103172981800_ehae356-B157","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/europace\/euab232","article-title":"2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"24","author":"Glikson","year":"2022","journal-title":"Europace"},{"key":"2025112103172981800_ehae356-B158","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjcard.2022.03.038","article-title":"Meta-Analysis of catheter ablation outcomes in patients with cardiac sarcoidosis refractory ventricular tachycardia","volume":"174","author":"Adhaduk","year":"2022","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B159","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamacardio.2021.4738","article-title":"Outcomes associated with catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"7","author":"Siontis","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2025112103172981800_ehae356-B160","doi-asserted-by":"crossref","first-page":"e017086","DOI":"10.1161\/JAHA.120.017086","article-title":"Atrial arrhythmias in clinically manifest cardiac sarcoidosis: incidence, burden, predictors, and outcomes","volume":"9","author":"Weng","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025112103172981800_ehae356-B161","first-page":"2663","article-title":"Cardiac manifestations of sarcoidosis: diagnosis and management","volume":"38","author":"Birnie","year":"2017","journal-title":"Eur Heart J"},{"key":"2025112103172981800_ehae356-B162","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"2025112103172981800_ehae356-B163","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B164","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.amjcard.2014.01.434","article-title":"Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias","volume":"113","author":"Cain","year":"2014","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B165","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1378\/chest.11-3214","article-title":"Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications","volume":"143","author":"Viles-Gonzalez","year":"2013","journal-title":"Chest"},{"key":"2025112103172981800_ehae356-B166","doi-asserted-by":"crossref","first-page":"e009203","DOI":"10.1161\/CIRCEP.120.009203","article-title":"Arrhythmias in cardiac sarcoidosis bench to bedside: a case-based review","volume":"14","author":"Rosenfeld","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025112103172981800_ehae356-B167","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1378\/chest.53.4.413","article-title":"Myocardial sarcoidosis","volume":"53","author":"Bashour","year":"1968","journal-title":"Dis Chest"},{"key":"2025112103172981800_ehae356-B168","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.hrcr.2018.06.014","article-title":"Multimodality imaging, electrophysiologic, electroanatomic, and histopathologic characterization of atrial sarcoidosis presenting with sinus arrest and reentrant right atrial flutter","volume":"4","author":"Bhaskaran","year":"2018","journal-title":"HeartRhythm Case Rep"},{"key":"2025112103172981800_ehae356-B169","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/eurheartj\/ehy150","article-title":"Left atrial sarcoidosis as a substrate for peri-mitral atrial flutter: an unusual, underlying atrial disease","volume":"39","author":"Hasegawa","year":"2018","journal-title":"Eur Heart J"},{"key":"2025112103172981800_ehae356-B170","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jacep.2018.12.011","article-title":"Atypical Re-entrant circuit of Cavo-tricuspid isthmus-dependent atrial flutter due to an atrial-septal conduction disturbance in a patient with cardiac sarcoidosis","volume":"5","author":"Koike","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"2025112103172981800_ehae356-B171","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0972-6292(16)30568-X","article-title":"Electrophysiological features of atrial flutter in cardiac sarcoidosis: a report of two cases","volume":"12","author":"Namboodiri","year":"2012","journal-title":"Indian Pacing Electrophysiol J"},{"key":"2025112103172981800_ehae356-B172","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ehjci\/jez051","article-title":"Left atrial involvement of cardiac sarcoidosis manifesting as left atrial re-entrant tachycardia","volume":"20","author":"Enzan","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B173","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jcmg.2020.08.037","article-title":"Multimodality imaging of atrial remodeling and risk of atrial fibrillation in patients with cardiac sarcoidosis","volume":"14","author":"Habibi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B174","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jcmg.2022.02.025","article-title":"Incidence and predictors of atrial fibrillation in cardiac sarcoidosis: a multimodality imaging study","volume":"15","author":"Niemel\u00e4","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B175","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1536\/ihj.19-265","article-title":"Atrial arrhythmias and atrial involvement in cardiac sarcoidosis","volume":"60","author":"Terasaki","year":"2019","journal-title":"Int Heart J"},{"key":"2025112103172981800_ehae356-B176","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2020.04.041","article-title":"Prevalence of atrial FDG uptake and association with atrial arrhythmias in patients with cardiac sarcoidosis","volume":"313","author":"Yodogawa","year":"2020","journal-title":"Int J Cardiol"},{"key":"2025112103172981800_ehae356-B177","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2025112103172981800_ehae356-B178","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4070\/kcj.2018.0432","article-title":"Management of arrhythmias associated with cardiac sarcoidosis","volume":"49","author":"Yada","year":"2019","journal-title":"Korean Circ J"},{"key":"2025112103172981800_ehae356-B179","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/jce.12424","article-title":"Catheter ablation of atrial arrhythmias in cardiac sarcoidosis","volume":"25","author":"Willner","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025112103172981800_ehae356-B180","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/clc.23263","article-title":"Outcome of catheter ablation of supraventricular tachyarrhythmias in cardiac sarcoidosis","volume":"42","author":"Willy","year":"2019","journal-title":"Clin Cardiol"},{"key":"2025112103172981800_ehae356-B181","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","article-title":"Isolated cardiac sarcoidosis: a focused review of an under-recognized entity","volume":"25","author":"Okada","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B182","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.amjcard.2018.10.021","article-title":"Cardiac Sarcoidosis","volume":"123","author":"Tan","year":"2019","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B183","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jchf.2020.01.014","article-title":"Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches","volume":"8","author":"Truby","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2025112103172981800_ehae356-B184","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1161\/CIR.0000000000001016","article-title":"Guidance for timely and appropriate referral of patients with advanced heart failure: a scientific statement from the American Heart Association","volume":"144","author":"Morris","year":"2021","journal-title":"Circulation"},{"key":"2025112103172981800_ehae356-B185","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10741-022-10284-0","article-title":"Heart transplantation in end-stage heart failure secondary to cardiac sarcoidosis: an updated systematic review","volume":"28","author":"Buttar","year":"2023","journal-title":"Heart Fail Rev"},{"key":"2025112103172981800_ehae356-B186","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.transproceed.2013.02.116","article-title":"Heart transplantation for end-stage heart failure due to cardiac sarcoidosis","volume":"45","author":"Perkel","year":"2013","journal-title":"Transplant Proc"},{"key":"2025112103172981800_ehae356-B187","first-page":"208","article-title":"Heart transplantation for advanced heart failure due to cardiac sarcoidosis","volume":"32","author":"Theofilogiannakos","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025112103172981800_ehae356-B188","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.healun.2007.05.006","article-title":"Outcome of heart transplantation in patients with sarcoid cardiomyopathy","volume":"26","author":"Zaidi","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"2025112103172981800_ehae356-B189","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.transproceed.2010.01.066","article-title":"Cardiac sarcoid in a heart transplant recipient: detection with cardiac magnetic resonance imaging","volume":"42","author":"Khan","year":"2010","journal-title":"Transplant Proc"},{"key":"2025112103172981800_ehae356-B190","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.healun.2005.02.016","article-title":"Recurrence of cardiac sarcoidosis in a heart transplant recipient","volume":"24","author":"Yager","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"2025112103172981800_ehae356-B191","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/MAT.0000000000001262","article-title":"Natural history of patients diagnosed with cardiac sarcoidosis at left ventricular assist device implantation or cardiac transplantation","volume":"67","author":"Schmidt","year":"2021","journal-title":"ASAIO J"},{"key":"2025112103172981800_ehae356-B192","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijcard.2018.11.131","article-title":"Treatment of cardiac sarcoidosis: a comparative study of steroids and steroids plus immunosuppressive drugs","volume":"276","author":"Ballul","year":"2019","journal-title":"Int J Cardiol"},{"key":"2025112103172981800_ehae356-B193","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.amjcard.2023.07.139","article-title":"Clinical response to tumor necrosis factor-alpha inhibitor therapy in the management of cardiac sarcoidosis","volume":"205","author":"Churchill","year":"2023","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B194","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1536\/ihj.22-406","article-title":"Optimal timing of serial (18)F-Fluoro-2-deoxyglucose positron emission tomography after prednisolone treatment introduction for cardiac sarcoidosis","volume":"64","author":"Ishizuka","year":"2023","journal-title":"Int Heart J"},{"key":"2025112103172981800_ehae356-B195","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cardfail.2019.02.018","article-title":"Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis","volume":"25","author":"Ning","year":"2019","journal-title":"J Card Fail"},{"key":"2025112103172981800_ehae356-B196","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jcmg.2022.05.015","article-title":"Effect of immunosuppressive therapy and biopsy status in monitoring therapy response in suspected cardiac sarcoidosis","volume":"15","author":"Rojulpote","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B197","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.11.142","article-title":"Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis","volume":"228","author":"Shelke","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025112103172981800_ehae356-B198","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.md.0000145367.17934.75","article-title":"Cardiac sarcoidosis: a retrospective study of 41 cases","volume":"83","author":"Chapelon-Abric","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"2025112103172981800_ehae356-B199","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/joa3.12583","article-title":"Clinical valuables related to resolution of complete or advanced atrioventricular block after steroid therapy in patients with cardiac sarcoidosis","volume":"37","author":"Nabeta","year":"2021","journal-title":"J Arrhythm"},{"key":"2025112103172981800_ehae356-B200","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jjcc.2013.07.007","article-title":"Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis","volume":"62","author":"Yodogawa","year":"2013","journal-title":"J Cardiol"},{"key":"2025112103172981800_ehae356-B201","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.hrcr.2020.06.028","article-title":"High-dose intravenous glucocorticoids are effective in the acute management of ventricular arrhythmias in cardiac sarcoidosis: a case series","volume":"6","author":"Slivnick","year":"2020","journal-title":"HeartRhythm Case Rep"},{"key":"2025112103172981800_ehae356-B202","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1002\/ehf2.14133","article-title":"Adalimumab for the treatment of cardiac sarcoidosis with multiple arrhythmias","volume":"9","author":"Li","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2025112103172981800_ehae356-B203","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/AC.66.6.2136967","article-title":"The anti-arrhythmic effects of prednisone in patients with sarcoidosis","volume":"66","author":"Mohsen","year":"2011","journal-title":"Acta Cardiol"},{"key":"2025112103172981800_ehae356-B204","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0972-6292(16)30569-1","article-title":"Sarcoidosis and atrial fibrillation: a rare association and interlink with inflammation","volume":"12","author":"Srivatsa","year":"2012","journal-title":"Indian Pacing Electrophysiol J"},{"key":"2025112103172981800_ehae356-B205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B206","first-page":"133","article-title":"Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block","volume":"20","author":"Kato","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025112103172981800_ehae356-B207","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2169\/internalmedicine.53.0794","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai","year":"2014","journal-title":"Intern Med"},{"key":"2025112103172981800_ehae356-B208","doi-asserted-by":"crossref","first-page":"101842","DOI":"10.1016\/j.nuclcard.2024.101842","article-title":"Role of serial (18)F-fludeoxyglucose positron emission tomography in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis","volume":"35","author":"Okafor","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"2025112103172981800_ehae356-B209","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijcard.2016.10.101","article-title":"Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis","volume":"227","author":"Padala","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025112103172981800_ehae356-B210","doi-asserted-by":"crossref","first-page":"e010952","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-Term corticosteroid-sparing immunosuppression for cardiac sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025112103172981800_ehae356-B211","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.amjcard.2023.06.101","article-title":"An international survey of current clinical practice in the treatment of cardiac sarcoidosis","volume":"203","author":"De Bortoli","year":"2023","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B212","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jjcc.2019.04.016","article-title":"Prognosis and risk stratification in cardiac sarcoidosis patients with preserved left ventricular ejection fraction","volume":"75","author":"Chiba","year":"2020","journal-title":"J Cardiol"},{"key":"2025112103172981800_ehae356-B213","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ejhf.1319","article-title":"Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres","volume":"20","author":"Fussner","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2025112103172981800_ehae356-B214","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1253\/circj.CJ-14-1275","article-title":"Effect of corticosteroid therapy on long-term clinical outcome and left ventricular function in patients with cardiac sarcoidosis","volume":"79","author":"Nagai","year":"2015","journal-title":"Circ J"},{"key":"2025112103172981800_ehae356-B215","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.amjcard.2015.12.033","article-title":"Effect of discontinuation of prednisolone therapy on risk of cardiac mortality associated with worsening left ventricular dysfunction in cardiac sarcoidosis","volume":"117","author":"Nagai","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B216","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.hrthm.2015.06.032","article-title":"Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block","volume":"12","author":"Orii","year":"2015","journal-title":"Heart Rhythm"},{"key":"2025112103172981800_ehae356-B217","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jjcc.2020.02.014","article-title":"Diagnostic accuracy of cardiac magnetic resonance imaging for cardiac sarcoidosis in complete heart block patients implanted with magnetic resonance-conditional pacemaker","volume":"76","author":"Orii","year":"2020","journal-title":"J Cardiol"},{"key":"2025112103172981800_ehae356-B218","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.amjcard.2014.11.028","article-title":"Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis","volume":"115","author":"Takaya","year":"2015","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B219","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ijcard.2014.07.042","article-title":"Reduction of myocardial inflammation with steroid is not necessarily associated with improvement in left ventricular function in patients with cardiac sarcoidosis: predictors of functional improvement","volume":"176","author":"Takaya","year":"2014","journal-title":"Int J Cardiol"},{"key":"2025112103172981800_ehae356-B220","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B221","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ehf2.12095","article-title":"Steroid pulse therapy was effective for cardiac sarcoidosis with ventricular tachycardia and systolic dysfunction","volume":"3","author":"Okabe","year":"2016","journal-title":"ESC Heart Fail"},{"key":"2025112103172981800_ehae356-B222","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir Med"},{"key":"2025112103172981800_ehae356-B223","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.amjcard.2019.07.067","article-title":"Infliximab for refractory cardiac sarcoidosis","volume":"124","author":"Harper","year":"2019","journal-title":"Am J Cardiol"},{"key":"2025112103172981800_ehae356-B224","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","article-title":"Cardiac sarcoidosis multi-center randomized controlled trial (CHASM CS-RCT)","volume":"220","author":"Birnie","year":"2020","journal-title":"Am Heart J"},{"key":"2025112103172981800_ehae356-B225","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/07853890.2022.2063375","article-title":"Comorbidities of sarcoidosis","volume":"54","author":"Tana","year":"2022","journal-title":"Ann Med"},{"key":"2025112103172981800_ehae356-B226","first-page":"101275","article-title":"Impact of comorbid heart failure among hospitalized patients with sarcoidosis: a United States population-based cohort study","volume":"49","author":"Casipit","year":"2023","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2025112103172981800_ehae356-B227","doi-asserted-by":"crossref","first-page":"1160089","DOI":"10.3389\/fcvm.2023.1160089","article-title":"Differences in phenotypes, symptoms, and survival in patients with cardiomyopathy-a prospective observational study from the Sahlgrenska CardioMyoPathy Centre","volume":"10","author":"Ljungman","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2025112103172981800_ehae356-B228","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jcmg.2014.11.017","article-title":"Late gadolinium enhancement among survivors of sudden cardiac arrest","volume":"8","author":"Neilan","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112103172981800_ehae356-B229","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jce.13119","article-title":"Outcome of patients with cardiac sarcoidosis who received cardiac resynchronization therapy: comparison with dilated cardiomyopathy patients","volume":"28","author":"Yufu","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025112103172981800_ehae356-B230","doi-asserted-by":"crossref","first-page":"e025803","DOI":"10.1161\/JAHA.122.025803","article-title":"The prognostic value of B-type natriuretic peptide in patients with cardiac sarcoidosis without heart failure: insights from ILLUMINATE-CS","volume":"11","author":"Miyakuni","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025112103172981800_ehae356-B231","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s12149-014-0860-7","article-title":"Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis","volume":"28","author":"Manabe","year":"2014","journal-title":"Ann Nucl Med"},{"key":"2025112103172981800_ehae356-B232","doi-asserted-by":"crossref","first-page":"e029481","DOI":"10.1161\/JAHA.123.029481","article-title":"Clinical outcomes and predictors of long-term survival in patients with and without previously known extracardiac sarcoidosis using machine learning: a Swedish Multicenter Study","volume":"12","author":"Bobbio","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2025112103172981800_ehae356-B233","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.3390\/diagnostics13142426","article-title":"Machine-Learning-Based diagnostics of cardiac sarcoidosis using multi-chamber wall motion analyses","volume":"13","author":"Eckstein","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"2025112103172981800_ehae356-B234","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1253\/circj.CJ-21-0265","article-title":"Deep learning algorithm to detect cardiac sarcoidosis from echocardiographic movies","volume":"86","author":"Katsushika","year":"2021","journal-title":"Circ J"},{"key":"2025112103172981800_ehae356-B235","doi-asserted-by":"crossref","DOI":"10.1007\/s11604-024-01546-y","article-title":"Machine learning approach using (18)F-FDG-PET-radiomic features and the visibility of right ventricle (18)F-FDG uptake for predicting clinical events in patients with cardiac sarcoidosis","author":"Nakajo","year":"2024","journal-title":"Jpn J Radiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/30\/2697\/58789562\/ehae356.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/30\/2697\/58789562\/ehae356.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:18:04Z","timestamp":1763713084000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/45\/30\/2697\/7699727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":235,"journal-issue":{"issue":"30","published-online":{"date-parts":[[2024,6,26]]},"published-print":{"date-parts":[[2024,8,9]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehae356","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8,7]]},"published":{"date-parts":[[2024,6,26]]}}}